Morphological, Structural, and Optical Properties of Single-Phase Cu(In,Ga)Se 2

The relatively small band gap values (~1 eV) of CuInSe2 thin films limit the conversion efficiencies of completed CuInSe2/CdS/ZnO solar cell devices. In the case of traditional two-stage growth techniques, limited success has been achieved to homogeneously increase the band gap by substituting indium with gallium. In this study, thermal evaporation of InSe/Cu/Gase precursors was exposed to an elemental Se vapour under defined conditions. This technique produced large-grained, single-phase Cu(In,Ga)Se2 thin films with a high degree of in-depth compositional uniformity. The selenization temperature, ramp time, reaction period, and the effusion cell temperature with respect to the Cu(In,Ga)Se2 films were optimized in this study. The homogeneous incorporation of Ga into CuInSe2 led to a systematic shift in the lattice spacing parameters and band gap of the absorber films. Under optimized conditions, gallium in cooperation resulted only in a marginal decrease in the grain size, X-ray diffraction studies confirmed single-phase Cu(In,Ga)Se2 material, and X-ray photoluminescence spectroscopy in-depth profiling revealed a uniform distribution of the elements through the entire depth of the alloy. From these studies optimum selenization conditions were determined for the deposition of homogeneous Cu(In,Ga)Se2 thin films with optimum band gap values between 1.01 and 1.21 eV

Effect of growth temperature on the structural, optical and luminescence properties of cadmium telluride nanoparticles

Cadmium telluride (CdTe) has been successfully prepared by a simple wet chemical process at different reaction temperatures. Temperature is one parameter that thermodynamically plays an important role in controlling the growth rate, morphology, size and size distribution of the as-prepared nanoparticles (NPs). Effect of this parameter was investigated on the growth, structural and optical properties of CdTe NPs. It was observed that the Powder X-ray diffraction (XRD) pattern for samples prepared at 50 °C had many impurities from unreacted precursors while those prepared at > 100 °C displayed polycrystalline NPs. The XRD results revealed that the structure of the CdTe NPs was cubic with the planes (111), (220), (311) being the main observed peaks. The crystallite sizes obtained from Scherrer formula increased with the increase in growth temperature (2.86–3.62 nm grown at 50–200 °C respectively). The scanning electron microscopy micrographs showed that the morphology of the nanoparticles possessed spherical-shaped particles over the entire surface. This was further confirmed by high resolution transmission electron microscopy micrographs which also displayed increase in the particle size with an increase in the growth temperature. In the optic study, the photoluminescence (PL) spectra displayed a red shift (540–560 nm) in emission as growth temperature increased from 50 to 200 °C. The highest PL peak intensity was realized at a growth temperature of 150 °C. Absorption band maxima were observed to shift towards longer wavelength for higher growth temperatures. The optical band gap decreased with increase in the growth temperature from 2.67 to 2.08 eV for 50–200 °C respectively

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019 : a systematic analysis for the Global Burden of Disease Study 2020, Release 1

Background Measuring routine childhood vaccination is crucial to inform global vaccine policies and programme implementation, and to track progress towards targets set by the Global Vaccine Action Plan (GVAP) and Immunization Agenda 2030. Robust estimates of routine vaccine coverage are needed to identify past successes and persistent vulnerabilities. Drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2020, Release 1, we did a systematic analysis of global, regional, and national vaccine coverage trends using a statistical framework, by vaccine and over time. Methods For this analysis we collated 55 326 country-specific, cohort-specific, year-specific, vaccine-specific, and dosespecific observations of routine childhood vaccination coverage between 1980 and 2019. Using spatiotemporal Gaussian process regression, we produced location-specific and year-specific estimates of 11 routine childhood vaccine coverage indicators for 204 countries and territories from 1980 to 2019, adjusting for biases in countryreported data and reflecting reported stockouts and supply disruptions. We analysed global and regional trends in coverage and numbers of zero-dose children (defined as those who never received a diphtheria-tetanus-pertussis [DTP] vaccine dose), progress towards GVAP targets, and the relationship between vaccine coverage and sociodemographic development. Findings By 2019, global coverage of third-dose DTP (DTP3; 81.6% [95% uncertainty interval 80.4-82 .7]) more than doubled from levels estimated in 1980 (39.9% [37.5-42.1]), as did global coverage of the first-dose measles-containing vaccine (MCV1; from 38.5% [35.4-41.3] in 1980 to 83.6% [82.3-84.8] in 2019). Third- dose polio vaccine (Pol3) coverage also increased, from 42.6% (41.4-44.1) in 1980 to 79.8% (78.4-81.1) in 2019, and global coverage of newer vaccines increased rapidly between 2000 and 2019. The global number of zero-dose children fell by nearly 75% between 1980 and 2019, from 56.8 million (52.6-60. 9) to 14.5 million (13.4-15.9). However, over the past decade, global vaccine coverage broadly plateaued; 94 countries and territories recorded decreasing DTP3 coverage since 2010. Only 11 countries and territories were estimated to have reached the national GVAP target of at least 90% coverage for all assessed vaccines in 2019. Interpretation After achieving large gains in childhood vaccine coverage worldwide, in much of the world this progress was stalled or reversed from 2010 to 2019. These findings underscore the importance of revisiting routine immunisation strategies and programmatic approaches, recentring service delivery around equity and underserved populations. Strengthening vaccine data and monitoring systems is crucial to these pursuits, now and through to 2030, to ensure that all children have access to, and can benefit from, lifesaving vaccines. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe

Tropical Data: Approach and Methodology as Applied to Trachoma Prevalence Surveys

PURPOSE: Population-based prevalence surveys are essential for decision-making on interventions to achieve trachoma elimination as a public health problem. This paper outlines the methodologies of Tropical Data, which supports work to undertake those surveys. METHODS: Tropical Data is a consortium of partners that supports health ministries worldwide to conduct globally standardised prevalence surveys that conform to World Health Organization recommendations. Founding principles are health ministry ownership, partnership and collaboration, and quality assurance and quality control at every step of the survey process. Support covers survey planning, survey design, training, electronic data collection and fieldwork, and data management, analysis and dissemination. Methods are adapted to meet local context and needs. Customisations, operational research and integration of other diseases into routine trachoma surveys have also been supported. RESULTS: Between 29th February 2016 and 24th April 2023, 3373 trachoma surveys across 50 countries have been supported, resulting in 10,818,502 people being examined for trachoma. CONCLUSION: This health ministry-led, standardised approach, with support from the start to the end of the survey process, has helped all trachoma elimination stakeholders to know where interventions are needed, where interventions can be stopped, and when elimination as a public health problem has been achieved. Flexibility to meet specific country contexts, adaptation to changes in global guidance and adjustments in response to user feedback have facilitated innovation in evidence-based methodologies, and supported health ministries to strive for global disease control targets

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

Combustion Synthesis of Nanocrystalline Ba_1.3Ca_0.7SiO₄ Semiconductors Using Urea as an Energy Efficient Fuel

The τ-phase Ba1.3Ca0.7SiO4 alkaline earth silicate powders were synthesized using the solution combustion technique. For this purpose, metal nitrate–urea mixtures were used as an oxidant and a fuel. Urea’s main function was to help lower the nominal combustion temperature (~550 °C) of the mixtures through exothermic reactions, leading to a relatively mild post-annealing temperature (~750 °C). If the urea concentration increased, the interconnected silicate particle size decreased with nanoscale crystallite (average, 33 ± 3 nm), affecting optical properties. Finally, the photoluminescence spectra suggested that the light emission was through trap sites, because the emitted blue and green lights (2.6 and 2.3 eV, respectively) were smaller than the bandgap (~3.2 eV) of the Ba1.3Ca0.7SiO4 semiconductor

Combustion Synthesis of Nanocrystalline Ba1.3Ca0.7SiO4 Semiconductors Using Urea as an Energy Efficient Fuel

The τ-phase Ba1.3Ca0.7SiO4 alkaline earth silicate powders were synthesized using the solution combustion technique. For this purpose, metal nitrate–urea mixtures were used as an oxidant and a fuel. Urea’s main function was to help lower the nominal combustion temperature (~550 °C) of the mixtures through exothermic reactions, leading to a relatively mild post-annealing temperature (~750 °C). If the urea concentration increased, the interconnected silicate particle size decreased with nanoscale crystallite (average, 33 ± 3 nm), affecting optical properties. Finally, the photoluminescence spectra suggested that the light emission was through trap sites, because the emitted blue and green lights (2.6 and 2.3 eV, respectively) were smaller than the bandgap (~3.2 eV) of the Ba1.3Ca0.7SiO4 semiconductor